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Dear Prof C. Zoccali, 
 
 
Please find enclosed the manuscript entitled “Diagnosis of cyst infection in patients with 
autosomal dominant polycystic kidney disease: attributes and limitations of the current 
modalities” that we submit for publication in NDT as a Review. 
 
As mentioned to you by Prof. M. Jadoul by e-mail and during the NDT Board meeting, our team 
has a longstanding interest for ADPKD, and particularly for the management of cyst infection in 
patients with ADPKD. The diagnosis of cyst infection remains a clinical challenge because of 
the lack of specific symptoms and the limitations of conventional imaging procedures. Still, 
recent studies have highlighted the potential usefulness of novel biomarker and imaging 
techniques in the diagnostic approach of cyst infection. The present manuscript reviews the 
attributes and limitations of these. 
 
On behalf of the authors*, I thank you in advance for your time and concern. 
 
 
Francois Jouret 
 
 
 
* Authors of the manuscript: R. Lhommel, O. Devuyst, Laurence Annet, Y. Pirson, Z. Hassoun 
and Nada Kanaan 
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Abstract 
 
Cyst infection is a diagnostic challenge in patients with autosomal dominant polycystic 
kidney disease (ADPKD) because of the lack of specific manifestations and limitations of 
conventional imaging procedures. Still, recent clinical observations and series have 
highlighted common criteria for this condition. Cyst infection is regarded as definite if 
confirmed by cyst fluid analysis showing bacteria and neutrophils, and as probable if all 4 
of the following features are concomitantly met: temperature of >38°C for >3 days, loin 
or liver tenderness, C-reactive protein plasma level of >5 mg/dl, and no evidence for 
intracystic bleeding on computed tomography (CT). In addition, the elevation of serum 
carbohydrate antigen 19.9 (CA19.9) has been proposed as a biomarker for hepatic cyst 
infection. Positron-emission tomography (PET) after intravenous injection of 18-
fluorodeoxyglucose (
18
FDG), combined with CT, proved superior to radiological imaging 
techniques for the identification and localization of kidney and liver pyocyst. The present 
review summarizes the attributes and limitations of these recent clinical, biological and 
imaging advances in the diagnosis of cyst infection in patients with ADPKD. 
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Introduction 
 
Autosomal dominant polycystic kidney disease (ADPKD) represents the most 
frequent inherited kidney disease
1
. It is characterized by the development of fluid-filled 
cysts in kidney and liver parenchyma, derived from various renal tubular segments and 
biliary ducts. Cyst growth causes organ enlargement leading to abdominal and/or loin 
discomfort. Liver cysts are not associated with hepatic dysfunction, whereas kidney cysts 
cause end-stage renal disease (ESRD) in more than 70% of ADPKD patients. In addition, 
cysts carry significant morbidity, including bleeding and infection. 
Cyst infection represents a serious complication of ADPKD. Its incidence has 
been calculated as 0.01 episode/patient/year, according to an 11-year retrospective 
monocentric series
2
. Predisposing conditions include age, female gender, and recent 
instrumentation of the urinary tract. In the chronic haemodialysis population, the 
prevalence of renal infection is significantly higher in ADPKD patients than in controls, 
and appears even more important in patients with a history of pyocyst before initiation of 
dialysis
3
. In the renal transplant recipient (RTR) population, the prevalence of urinary 
tract infections in patients with ADPKD does not appear to be increased
4
. On the whole, 
cyst infection accounts for 15% of all causes of hospitalizations of ADPKD patients
2,5
. 
Pathogens usually include enteric flora, with E. coli being the most common agent. The 
retrograde route via the ureters or the biliary ducts is the presumed mechanism of cyst 
infection in kidney and liver, respectively. The identification of the causative germ is 
lacking in more than half of cases, similarly to the rate observed in the general population 
with severe sepsis. Sallee et al. reported that urine and blood cultures were respectively 
positive in 39% and 24% episodes of the largest series of 33 patients with 41 kidney 
(n=31) or liver (n=10) cyst infections
2
. Similarly, the bacterial agent could be identified 
in 53% of our series of 15 episodes of kidney (n=5) or liver (n=10) cyst infections
5
. Thus, 
although the identification of the infectious agent is essential for tailoring the antibiotic 
therapy, its poor yield limits its diagnostic usefulness. Furthermore, it does not reliably 
distinguish cystic from non-cystic infections.  
The diagnosis of cyst infection is uneasy because of the various, most often non-
specific, clinical manifestations and the limitations of conventional imaging techniques. 
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Proving cyst infection requires cyst fluid analysis. However, this is not always possible or 
indicated, so that diagnosis practically relies on a constellation of concurrent clinical, 
biological and radiological parameters. Sallee et al. proposed criteria commonly used in 
clinical routine on the basis of an 11-year retrospective series of pyocysts in ADPKD 
patients
2
:  
• Cyst infection is definite when confirmed by cyst aspiration showing neutrophils 
and bacteria; 
• Cyst infection is probable in the concurrent manifestation of 4 conditions: fever 
(temperature >38°C for >3d), abdominal tenderness in kidney or liver area, 
increased C-reactive protein levels (CRP, > 5 mg/dl), and the absence of CT 
argument for recent intra-cystic bleeding suggested by spontaneous intra-cystic 
density above 25 Hounsfield units. 
 
None of these criteria kept alone is specific for cyst infection, except pus analysis. 
They do not allow to precisely locate the pyocyst, and cannot rule out a secondary 
infection complicating a cyst haemorrhage. In liver cyst infection, the combination of 
early percutaneous drainage and antimicrobial therapy proved more efficient than 
antibiotics alone
6
. Therefore, the identification of the pyocyst is important in patients 
presenting with suspected liver cyst infection. Furthermore, type and duration of 
antibiotic therapy vary according to the infectious site, the causative agent and the 
patient’s medical history
2
. Nephrectomy or partial hepatectomy may be required because 
of persistent or recurrent cyst infection, a fortiori in waiting list candidates for kidney 
transplantation.  
This review summarizes recent advances in cyst infection diagnosis. Elevated 
serum levels of the carbohydrate antigen 19-9 (CA19-9) may represent a novel biomarker 
for liver cyst infection. Positron-emission tomography (PET) after intravenous injection 
of 18-fluoro-deoxy-glucose (
18
FDG), coupled with computed tomography (CT), proved 
reliable not only in detecting but also locating kidney and liver pyocyst. Prospective trials 
are still required to (i) define the gold-standard of cyst infection, (ii) establish the 
sensitivity and specificity of the new diagnostic modalities, and (iii) propose a 
standardized approach for cyst infection in ADPKD patients. 
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Serum levels of the carbohydrate antigen 19-9 (CA19-9) in liver cyst infection 
 
Liver cysts represent the most common extra-renal manifestation in ADPKD, and 
are associated with significant morbidities. Recent observations using the biomarker of 
bilio-pancreatic malignancies, CA19-9, showed promising results in the diagnosis of liver 
cyst infection
7
.  
CA19-9 is a 36-kDa glycolipid produced by bile duct cells. Its biosynthesis 
depends on the α-1,4-fucosyltransferase pathway. This enzyme is lacking in rare Lewis 
blood group-negative individuals, who therefore show undetectable serum levels of 
CA19.9. By contrast, increased serum CA19-9 levels have been reported in non-
malignant conditions, including biliary obstruction and benign hydronephrosis. High 
CA19-9 levels have also been measured in non-infected cyst fluid of patients with benign 
sporadic liver cysts or with polycystic liver disease (PCLD)
8
. The production of CA19.9 
probably results from secretion by epithelial cells lining the cysts, as illustrated by 
immunohistochemistry
7
. Of note, epithelial cells lining renal cysts inconsistently express 
a low level of cytoplasmic CA19-9. Leakage from liver cysts and/or direct secretion into 
the circulation cause significantly higher steady-state serum CA19-9 levels in patients 
with ADPKD or PCLD than in controls
7,8
, which limits the use of standard upper values 
(<35 U/mL) in this population. The 90
th
 percentile of serum CA19-9 levels in our series 
of 30 ADPKD patients was 106 U/mL
7
. Such elevation of CA19.9 levels is similar in 
patients with either ADPKD or PCLD, correlates with cyst fluid levels of CA19.9, and is 
not influenced by age or gender
8
.  
Isolated reports showed that CA19.9 levels are further increased in serum and cyst 
fluid of patients with infected simple liver cysts. Similarly, serum CA19-9 levels increase 
in ADPKD patients during liver cyst infection and decrease with resolution of the 
infection. Moreover, extremely high CA19-9 levels (>100,000 U/mL) have been 
measured in infected cyst fluids
7
. These observations suggest that liver cyst infection 
induces CA19-9 secretion in cyst fluid and/or its release into the bloodstream, resulting in 
elevated serum CA19-9 levels. Such increase of serum CA19-9 levels may thus represent 
a helpful diagnostic marker of liver cyst infection. However, a CA19-9 cut-off level with 
acceptable specificity and sensitivity to make diagnosis of a liver cyst infection in 
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ADPKD patients is currently lacking. Because of inter-individual variations, comparison 
to baseline levels in each ADPKD patient may be more useful to interpret elevated 
CA19-9 levels in case of suspected liver cyst infection.  
 
 
 
Page 9 of 21 Nephrology Dialysis Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
- 7 - 
CT and MRI in the diagnosis of kidney and liver cyst infection 
 
Chronic parenchyma injury and cyst growth are associated with profound 
morphological disorganization of kidney and liver anatomy and with cyst heterogeneity. 
Consequently, conventional imaging procedures, like CT and MRI, frequently fail to 
confidently locate cyst infection. Wall thickening and heterogeneous content are usually 
suggestive of cyst infection
9
 (Figure 1, Panel A). However, the presence of intra-cystic 
cellular debris, hyperintense on CT, shows a poor specificity to differentiate infected 
from non-infected cysts in ADPKD patients. In addition, contrast enhancement lining 
cyst walls can be caused by either inflammation or residual functional parenchyma. In the 
series of Sallee et al., CT and MRI showed contributive images in 18% and 40% of cyst 
infection cases, respectively, and yielded negative results in more than half of patients 
with a definite diagnosis of cyst infection
2
. In a prospective series of 10 consecutive 
patients with suspected cystic infection, the independent revision of CT images acquired 
during PET/CT was unable to locate any of the infected cysts
10
. This study included 6 
patients with ADPKD and 4 patients with multiple kidney cysts.  
An additional limitation of CT in ADPKD patients with chronic kidney disease 
(CKD) is the relative or absolute contra-indication for the use of intravenous radiological 
contrast medium. Administration of contrast agent was only achieved in 25% of cases 
reported by Piccoli et al.
10
. Similarly, in our series of 27 suspicions of abdominal 
infection, injection of contrast agent was performed in 30% of cases
5
. CT yielded 
contributive results in 5 cases, including 1 liver cyst infection, 1 kidney cyst infection, 1 
diverticulitis and 2 intra-cystic bleedings. However, CT failed to detect the pyocyst in 
85% of cases. Such limited information gained by CT after administration of contrast 
material does most often not outweigh its potential harm, which further questions its use 
in clinical routine.  
The accuracy of MRI, with or without gadolinium injection, in cyst infection 
diagnosis remains largely unknown. Findings of infected cysts using T1- and T2-
weighted MRI may mimic those of normal cysts. Intravenous injection of Gd
3+
 before 
MRI is associated with a parietal enhancement highly suggestive of cyst infection
6,11
. 
However, the association between nephrogenic systemic fibrosis (NSF) and exposure to 
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Gd
3+
-based contrast agents has greatly affected the use of MRI in patients with CKD. 
Current recommendations advocate that a patient should be considered to be at risk for 
NSF with a glomerular filtration rate (GFR) of <30 mL/min/1.73 m
2
. Efforts have been 
done to develop both lower risk Gd
3+
-based contrast agents and the contribution of Gd
3+
-
free MRI. Hence, diffusion-weighted MRI may help distinguish infected from non-
complicated cysts in ADPKD patients on the basis of a decreased apparent diffusion 
coefficient value
12
 (Figure 1, Panel B). These encouraging preliminary observations 
need further prospective investigations. 
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Radiolabeled-leukocyte scintigraphy in the diagnosis of kidney and liver cyst 
infection 
 
To complement radiological procedures in the work-up of infectious site 
localization, techniques using radiolabeled leukocytes have been developed. Particularly, 
111
In-leukocyte scanning allowed the identification of renal cyst infection in ADPKD 
patients in whom other noninvasive imaging procedures had failed
13
. In a retrospective 
series of liver cyst infections combining 5 cases from the Mayo Clinic institution and 9 
case reports from the literature, 
111
In-leukocyte scans were positive in all 4 ADPKD 
patients in whom they were performed
6
. 
111
In-leukocyte scanning requires the handling of 
blood derivatives and the ex temporane in vitro labeling process, as well a 24-hour delay 
before imaging. 
111
In scintigraphy is characterized by poor spatial resolution, low 
sensitivity, high radiation activity, and significant inter-observer variability. Moreover, 
the use of 
111
In-leukocyte scanning in febrile RTR raises concerns because of unspecific 
accumulation of WBC in renal and pulmonary parenchymae
14
.  
Hexamethylpropylene amine oxime (HMPAO) represents an alternative lipophilic 
chelator to efficiently label leukocytes with 
99m
Technetium (
99m
Tc). Radiation 
characteristics of 
99m
Tc-HMPAO are more favorable for imaging than 
111
In, particularly 
for single photon emission computed tomography (SPECT). Furthermore, the dual 
modality technique combining CT with SPECT using radiolabeled WBC has been 
associated with a diagnostic yield of 85% of cases with abdominal infections
15
. The 
relevance of SPECT/CT in cyst infection diagnosis in ADPKD patients is currently 
unknown.  
Page 12 of 21Nephrology Dialysis Transplantation
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
- 10 - 
 
18
FDG PET/CT in the diagnosis of kidney and liver cyst infection 
 
In the general population, 
18
FDG-PET/CT imaging represents a reliable tool for 
the detection of tissue infection on the basis of the high metabolic activity and increased 
uptake of the radiolabelled glucose analogue, 
18
FDG, by inflammatory cells
16
. 
Importantly, 
18
FDG is not nephro- or hepatotoxic, and has been successfully used in 
patients with renal function ranging from mildly reduced GFR to ESRD
2,17
. First, 
18
FDG-
PET alone proved helpful in identifying or excluding renal and hepatic cyst infection in 
case reports and two retrospective series
2,11,18
. To further improve the localization of 
infectious sites, PET was combined with CT to integrate metabolic data from PET with 
anatomical information from CT
16
. In our series, 
18
FDG-PET/CT yielded positive results 
in 87% of cyst infection cases
5
. PET/CT was considered as positive for cyst infection 
when 
18
FDG uptake was focally increased lining at least one cyst, in contrast with 
physiologic accumulation in parenchyma and at distance from pelvicalyceal excretion 
(Figure 2). PET/CT yielded 2 false-negative results in a diabetic RTR during the 
immediate post-transplantation period and in a 62-year-old non-diabetic woman with 
stage IV CKD. By contrast, 3 liver pyocysts could be percutaneously drained only after 
localization by PET/CT. The median delay between the onset of symptoms and PET/CT 
imaging was 9 days, and the mean maximal standardized uptake value (SUVmax) 
reached 5.1 +/- 1.7 g/ml. The measurement of SUVmax allows standardized 
quantification of the inflammatory process in addition to the visual evaluation
17
. 
Repeated measurements of SUVmax may help follow up the inflammatory process over 
time. Piccoli et al. reported on the clinical management of 10 patients with suspected 
cystic infection, which was tailored upon 
18
FDG-PET/CT results
10
. PET/CT identified 5 
kidney and 1 liver cyst infections. Mean SUVmax reached 8.4 +/- 5.4 g/ml on initial 
PET/CT images. The follow-up of 4 patients included a comparative PET/CT performed 
3 to 6 weeks later, which showed a visual reduction of pathological 
18
FDG uptake but no 
significant change of SUVmax. Three patients underwent a third PET/CT 7 to 9 weeks 
after the initial imaging, which disclosed no residual 
18
FDG uptake. Of note, the 
normalization of serum CRP levels preceded PET/CT normalization. The clinical 
relevance of persistent altered PET/CT images in treated infectious diseases remains 
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unclear. Literature in oncology supports that the follow-up by 
18
FDG-PET/CT of 
therapeutic responses to chemo- or radiotherapy varies from 3 to 12 weeks upon the type 
of cancer and administered therapy. However, the pathophysiology of infection is 
intrinsically different from neoplasia, and cyst infection is associated with the additional 
challenge of antibiotic diffusion into a chronically damaged organ and a cystic cavity. 
Consequently, 
18
FDG-PET/CT probably represents the optimal tool for the detection and 
localization of pyocysts in ADPKD patients, but its role in the follow-up after antibiotic 
therapy remains uncertain.  
PET/CT in ADPKD patients with suspected cyst infection offers the additional 
advantage to entirely scan the abdominal cavity, thereby occasionally identifying non-
cystic inflammatory disorders and adjusting the therapy. In our series, 
18
FDG-PET/CT 
identified distinct non-cystic infectious conditions, such as angiocholitis, small intestine 
diverticulitis associated with psoas abscess, right colon diverticulitis, prostatitis, kidney 
graft pyelonephritis, and infection of abdominal aorta aneurysm. PET/CT results 
significantly changed the management of 26% cases
5
. Moreover, PET/CT evidenced 2 
kidney cyst infections although both patients did not meet all 4 of the standardized 
criteria
6
. In the series of Piccoli et al., PET/CT imaging excluded cyst infection in 4/10 
cases, but collaterally detected abnormal 
18
FDG uptake in a peripancreatic lymph node 
caused by mesenchymal neoplasia
10
.  
The advantages of 
18
FDG-PET/CT are rapid imaging, minimal labor intensity, 
high target-to-background ratio, high inter-observer agre ment, and a simultaneous co-
registration with low-dose CT without administration of contrast medium
17
. Limitations 
of PET/CT include its cost, restricted availability, and relative inability to reliably 
distinguish infectious from non-infectious inflammation or malignancy. The 
differentiation of 
18
FDG accumulation in residual functional renal parenchyma versus 
that in inflammatory cells lining pyocysts remains debated
16
. The distinction between 
cyst infection and pyelonephritis may be uneasy. PET/CT pattern of pyelonephritis 
usually includes a diffuse 
18
FDG uptake in an edematous cortex and loco-regional 
hypermetabolic adenopathies, which contrasts with the focally increased uptake of 
18
FDG 
lining the pyocyst. Besides infectious processes, 
18
FDG uptake can be increased in other 
conditions, like cancer. The actual risk of malignancy in ADPKD patients does not seem 
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to be increased
19
. Liver cystadenocarcinoma is very uncommon, and most kidney tumors 
show low-grade malignancy leading to low 
18
FDG uptake. However, “false-positive” rate 
of 
18
FDG-PET/CT in cyst infection diagnosis remains to be prospectively investigated. 
The relevance of alternative tracers, like 
18
F-L-thymidine and 
124
I-cG250, should be 
addressed in patients with kidney cyst infection. Finally, PET/CT has not been evaluated 
in intra-cystic bleeding, the main differential diagnosis of cyst infection in ADPKD 
patients. Accumulation of 
18
FDG has been reported in the setting of extra-renal 
hematoma
20
. Thus, the specificity of 
18
FDG-PET/CT for cyst infections remains to be 
assessed. Conversely, 
18
FDG uptake may vary upon its diffusion into the lesion, the size 
of the lesion, and the degree of respiratory mobility of the organ under investigation
17
. 
Each of these conditions may be responsible for “false-negative” PET/CT. Therefore, the 
collaboration of clinicians with radiologists and physicians in nuclear medicine is 
essential to optimize the interpretation of PET/CT images in the clinical context of 
suspected cyst infection.  
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Perspectives in the diagnostic approach for suspected kidney and liver cyst infection 
 
The main diagnostic objectives in ADPKD patients presenting with suspected cyst 
infection are to (1) rule out non-cystic infections, (2) determine the location of pyocysts, 
(3) identify the causative germ, and (4) exclude concomitant conditions, like urinary tract 
obstruction. Practically, the diagnosis of cyst infection relies on the concurrent 
manifestation of common clinical, biological and radiological parameters summarized by 
Sallee et al.
2
. The identification of the infectious agent by blood and/or urine cultures is 
essential for tailoring the antibiotic therapy, but does not reliably distinguish cystic from 
non-cystic infections. Elevated serum CA19.9 levels have been associated with liver cyst 
infection, although a diagnostic cut-off level is still lacking
24
. The large inter-individual 
variations suggest that a comparative assessment to baseline CA19-9 levels in each 
ADPKD patient might be more useful. Finally, current literature highlights the limitations 
of conventional imaging techniques, like CT and MRI, and emphasizes the promising 
role of 
18
FDG-PET/CT in the identification and localization of kidney and liver cyst 
infection in ADPKD patients. However, several questions need to be addressed regarding 
the sensibility and specificity of each clinical, biological and radiological sign of cyst 
infection, individually and in combination with each other. Clinical trials should focus on 
determining the most appropriate timing of biological and imaging investigations after 
the onset of symptoms. The cost-benefit ratio and eventual pattern of repeated tests after 
therapy initiation, like sequential measurements of serum CA19.9 levels or follow-up 
imaging by PET/CT, remain to be established. Particularly, the limited availability of 
PET imaging, as well as the ongoing budget restrictions in Health Care systems, may 
hamper the systematic use of 
18
FDG-PET/CT in the diagnosis of cyst infection. In 
addition, the specificity of each diagnostic modality should be addressed in comparison 
to non-infectious cyst complications, like haemorrhage. Finally, innovative imaging 
techniques, like PET/MRI, are currently under clinical evaluation and may further 
improve our diagnostic strategy in ADPKD patients presenting with fever and abdominal 
pain. 
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Legends 
 
Figure 1. Representative computed tomography (CT) and magnetic resonance 
imaging (MRI) of cyst infection in patients with autosomal dominant polycystic 
kidney disease (ADPKD) 
Panel A. CT without intravenous administration of contrast agent shows a heterogeneous 
peripheral cyst of the lower pole of the left kidney surrounded by edematous adipose 
tissue and a thickened renal fascia (arrowhead), in a female renal transplant recipient with 
ADPKD presenting with fever, abdominal pain and increased plasma C-reactive protein 
levels. Blood culture grew Escherichia coli. Right nephrectomy had been performed 
before renal transplantation for recurrent cyst infections.  
Panel B. Diffusion-weighted MRI shows a heterogeneous cyst with thick wall and 
hyperintense signal on diffusion (β value = 20 s/mm²) in the lower internal pole of the 
left kidney (arrowhead) in a male renal transplant recipient with ADPKD presenting with 
fever, left loin tenderness and increased plasma C-reactive protein. Blood and urine 
cultures grew Escherichia coli. Right nephrectomy had been performed at the time of 
renal transplantation.  
 
 
Figure 2. Representative positron-emission tomography (PET) after intravenous 
injection of 18-fluoro-deoxy-glucose (
18
FDG), coupled with computed tomography 
(CT), of cyst infection in patients with autosomal dominant polycystic kidney 
disease (ADPKD) 
18
FDG-PET imaging in maximal intensity projection mode (Panel A) and fused 
18
FDG-
PET/CT slices in coronal (Panel B) and transverse planes (Panel C) disclose a 
pathological accumulation of 
18
FDG surrounding a cyst located at the lower pole of the 
native left kidney (white and black arrows) in a female renal transplant recipient with 
ADPKD presenting with fever, abdominal pain and increased plasma C-reactive protein 
levels. The maximal standardized uptake value (SUVmax) reaches 3.51 g/ml. SUVmax is 
calculated by drawing a region of interest around the hottest spot on PET images, and 
uses the formula: [Pixel value (Bq/ml) x patient weight (Kg)] / [injected dose (Bq) x 1000 
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(g/kg)]. Blood culture grew Escherichia coli. Right nephrectomy had been performed 
before renal transplantation for recurrent cyst infections. Note that physiological 
excretion of 
18
FDG is observed in the kidney graft (red arrow).   
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